Safety of sublingual immunotherapy with a monomeric allergoid in very young children

被引：90

作者：

Agostinis, F ^{[1
]}

Tellarini, L ^{[1
]}

Canonica, GW ^{[1
]}

Falagiani, P ^{[1
]}

Passalacqua, G ^{[1
]}

机构：

[1] Dept Internal Med Padiglione Maragliano, I-16132 Genoa, Italy

来源：

ALLERGY | 2005年 / 60卷 / 01期

关键词：

children; safety; side effects; sublingual immunotherapy;

D O I：

10.1111/j.1398-9995.2004.00616.x

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

[No abstract available]

引用

页码：133 / 133

页数：1

共 5 条

[1]

BOUSQUET J, 1998, ALLERGY S44, V53, P11

[2]

BOUSQUET J, 2001, J ALLERGY CLIN IMM S, V111, P242

[3] Immunotherapy with a standardized Dermatophagoides pteronyssinus extract .6. Specific immunotherapy prevents the onset of new sensitizations in children [J].

DesRoches, A ;

Paradis, L ;

Menardo, JL ;

Bouges, S ;

Daures, JP ;

Bousquet, J .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1997, 99 (04) :450-453

[4] Post-marketing surveillance study on the safety of sublingual immunotherapy in pediatric patients [J].

Di Rienzo, V ;

Pagani, A ;

Parmiani, S ;

Passalacqua, G ;

Canonica, GW .

ALLERGY, 1999, 54 (10) :1110-1113

[5] Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-Study) [J].

Möller, C ;

Dreborg, S ;

Ferdousi, HA ;

Halken, S ;

Host, A ;

Jacobsen, L ;

Koivikko, A ;

Koller, DY ;

Niggemann, B ;

Norberg, LA ;

Urbanek, R ;

Valovirta, E ;

Wahn, U .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2002, 109 (02) :251-256

← 1 →